Department of Urology
Tel.
+41 43 253 08 84
14. Interdisciplinary Uro-Oncology Symposium 2024
Hot Topics in Uro-Oncology: At this annual training for specialists in urology, oncology, radiology and pathology, the latest findings and developments in prostate, kidney and bladder cancer are presented by internationally renowned speakers. Stay up to date and exchange ideas with colleagues on site!
Location
Careum Auditorium
8032 Zürich
Date
02.02.2024
Time
9.45 a.m. - 4.30 p.m.
Credits
SGU 6, SGMO 5, SRO 5
Program
| 9.00 h | Registration and coffee |
|---|---|
| 9.40 h | Welcome address Daniel Eberli, Prof. Dr. Dr., USZ Zürich, CH |
Session I: Robotic Surgery in Uro-oncologyModeration: Moderation: Cédric Poyet, Prof. Dr. |
|
| 9.45 h | Robotic Partial Nephrectomy for complex Renal Tumors – Boundaries and Challenges Ben Challacombe, Dr. |
Session II: Rare urogenital cancersModeration: Anja Lorch, Prof. Dr. Discussion “Tumor genomic profiling for urogenital malignancies: Benefit or Non-sense?” |
|
| 10.15 h | Management of penile cancer and importance of centralization of rare urogenital malignancies Ben Ayres, Dr. |
| 10.45 h | Evidence based adequate Follow-up of testicular cancer – What has been changed over the years?
Richard Cathomas, Prof. Dr. |
George Mayor Honorary LectureModeration: Prof. Dr. Dr. D. Eberli |
|
| 11.15 h | Achievements in Medical and Surgical Treatment of Testicular Cancer – Past, Present, Future Axel Heidenreich, Univ.-Prof. Dr. Dr. h.c. |
| 12.00 h | Lunch break |
Session III: Localized Prostate CancerModeration: Prof. Dr. C. Poyet |
|
| 13.15 h | Time to stop calling Gleason pattern 3 prostate disease “cancer” Andrew Vickers, PhD Dr. |
| 13.45 h | How much re-biopsy is still needed during active surveillance for low risk prostate cancer Veeru Kasivisvanathan, Prof. Dr. |
| 14.15 h | Coffee Break |
Session IV: Advanced / Oligometastatic diseaseModeration: Matthias Guckenberger, Prof. Dr. |
|
| 14.45 h | Radiotherapy of oligometastatic prostate cancer – Current evidence and future? Piet Ost, Prof. Dr. |
| 15.15 h | Future treatment strategies for locally advanced and metastatic urothelial cancer? Maria de Santis, Prof. Dr. |
| 15.45 h | Closing remarks Prof. Dr. C. Poyet, USZ Zürich, CH |
Speakers
- Ben Ayres, Dr.
Consultant Urological surgeon
St. Georges University Hospitals London,
UK - Richard Cathomas, Prof. Dr.
Medizinische Onkologie und
Hämatologie
Kantonsspital Graubünden
Chur, Switzerland - Ben Chalacombe, Dr.
Consultant urological surgeon
Guy’s Hospital & King’s College London,
UK - Axel Heidenreich, Univ.-Prof. Dr. Dr. h.c.
Urologie, Uro-Onkologie, spezielle
urologische und Roboter-assistierte
Chirurgie
Universitätsklinikum Köln
Köln, Deutschland - Veeru Kasivisvanathan, Prof. Dr.
Division of Surgery & Interventional
Science
University College London
London, UK - Piet Ost, Prof. Dr.
Faculty of Medicine and Health Sciences
Ghent University
Ghent, Belgium - Maria de Santis, Prof. Dr.
Interdisziplinäre Uro-Onkologie
Charité – Universitätsmedizin Berlin
Berlin, Deutschland - Andrew Vickers, PhD Dr.
Department of Epidemiology and
Biostatistics, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, USA